ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Yanfen Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0456-9232; OpenAlex author ID A5022046028. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yanyan Da · 1 shared paper, 2026 · strength 0.22
- Paper Histone lactylation increases CXCL1 expression for neutrophil infiltration and immune escape in pancreatic cancer. DOI 10.1038/s41467-026-69311-5 ↗
Peng Zhang · 1 shared paper, 2026 · strength 0.22
- Paper Histone lactylation increases CXCL1 expression for neutrophil infiltration and immune escape in pancreatic cancer. DOI 10.1038/s41467-026-69311-5 ↗
Chengsheng Zhang · 1 shared paper, 2026 · strength 0.22
- Paper Histone lactylation increases CXCL1 expression for neutrophil infiltration and immune escape in pancreatic cancer. DOI 10.1038/s41467-026-69311-5 ↗
Chenxi Li · 1 shared paper, 2026 · strength 0.22
- Paper Histone lactylation increases CXCL1 expression for neutrophil infiltration and immune escape in pancreatic cancer. DOI 10.1038/s41467-026-69311-5 ↗
Xiao-Qin Wang · 1 shared paper, 2018 · strength 0.11
- Paper [Detection of chitinase 3-like 1 combined with other biomarkers for diagnosis of pancreatic cancer]. DOI 10.3969/j.issn.1673-4254.2018.04.13 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.